[1]
J. Bobde, R. Kadam, and D. Bhosle, “Comparative study of safety and efficacy profile of repaglinide and voglibose on targeting post prandial hyperglycemia in patients with newly diagnosed type II diabetes mellitus”, Int J Basic Clin Pharmacol, vol. 7, no. 12, pp. 2325–2331, Nov. 2018.